Connect with us

Brownstone Institute

It Was Birx. All Birx.

Published

35 minute read

BY DEBBIE LERMAN

In two previous articles, I looked into the shady circumstances surrounding Deborah Birx’s appointment to the White House Coronavirus Response Task Force and the laughable lack of actual science behind the claims she used to justify her testing, masking, distancing and lockdown policies.

Considering all that, the questions arise: Who was actually in charge of Deborah Birx and whom was she working with?

But first: Who cares?

Here’s why I think it’s important: If we can show that Birx and the others who imposed totalitarian anti-scientific testing, masking, social distancing, and lockdown policies, knew from the get-go that these policies would not work against an airborne respiratory virus, and nevertheless they imposed them FOR REASONS OTHER THAN PUBLIC HEALTH, then there is no longer acceptable justification for any of those measures.

Furthermore, whatever mountains of post-facto bad science were concocted to rationalize these measures are also completely bunk. Instead of having to go through each ridiculous pseudo-study to demonstrate its scientific worthlessness, we can throw the whole steaming pile in the garbage heap of history, where it belongs, and move on with our lives.

In my admittedly somewhat naive optimism, I also hope that by exposing the non-scientific, anti-public-health origins of the Covid catastrophe, we may lower the chances of it happening again.

And now, back to Birx.

She did not work for or with Trump

We know Birx was definitely not working with President Trump, although she was on a task force ostensibly representing the White House. Trump did not appoint her, nor did the leaders of the Task Force, as Scott Atlas recounts in his revelatory book on White House pandemic lunacy, A Plague Upon Our House. When Atlas asked Task Force members how Birx was appointed, he was surprised to find that “no one seemed to know.” (Atlas, p. 82)

Yet, somehow, Deborah Birx – a former military AIDS researcher and government AIDS ambassador with no training, experience or publications in epidemiology or public health policy –  found herself leading a White House Task Force on which she had the power to literally subvert the policy prescriptions of the President of the United States.

As she describes in The Silent Invasion, Birx was shocked when “at the halfway point of our 15 Days to Slow the Spread campaign, President Trump stated that he hoped to lift all restrictions by Easter Sunday.” (Birx, p. 142) She was even more dismayed when “mere days after the president had announced the thirty-day extension of the Slow the Spread campaign to the American public” he became enraged and told her “‘We will never shut down the country again. Never.’” (Birx, p. 152)

Clearly, Trump was not on board with the lockdowns, and every time he was forced to go along with them, he became enraged and lashed out at Birx – the person he believed was forcing him.

Birx laments that “from here on out, everything I worked toward would be harder—in some cases, impossible,” and goes on to say she would basically have to work behind the scenes against the President, having “to adapt to effectively protect the country from the virus that had already silently invaded it.” (Birx, pp. 153-4)

Which brings us back to the question: Where did Birx get the nerve and, more mysteriously, the authority to so blithely act in direct opposition to the President she was supposed to serve, on matters affecting the lives of the entire population of the United States?

Atlas regrets what he thinks was President Trump’s “massive error in judgment.” He argues that Trump acted “against his own gut feeling” and “delegated authority to medical bureaucrats, and then he failed to correct that mistake.” (Atlas, p. 308)

Although I believe massive errors in judgment were not unusual for President Trump, I disagree with Atlas on this one. In the case of the Coronavirus Response Task Force, I actually think there was something much more insidious at play.

Trump had no power over Birx or pandemic response

Dr. Paul Alexander, an epidemiologist and research methodology expert who was recruited to advise the Trump administration on pandemic policy, tells a shocking story in an interview with Jeffrey Tucker, in which bureaucrats at the Department of Health and Human Services (HHS) and lawyers from the Justice Department told him to resign, despite direct orders from President Trump and the White House: “We want you to understand that President Trump has no power,” they reportedly told Alexander. “He cannot tell us what to do.”

Alexander believes these bureaucrats represented the “deep state” which, he was told repeatedly, had decided first not to hire or pay him, and then to get rid of him. Alexander also writes in an upcoming exposé that the entrenched government bureaucracy, particularly at the NIH, CDC, and WHO, used the pandemic response to doom President Trump’s chances for reelection.

Was the entire anti-scientific totalitarian pandemic response, all over the world, a political maneuver to get rid of Trump? It’s possible. I would contend, however, that the politics were only a sideshow to the main event: the engineered virus lab leak and coverup. I believe the “deep state” Alexander repeatedly butted up against was not just the entrenched bureaucracy, but something even deeper and more powerful.

Which brings us back to deep state frontwoman Deborah Birx.

After lamenting Trump’s delegation of authority to “medical bureaucrats,” Scott Atlas also hints at forces beyond Trump’s control. “The Task Force was called ‘the White House Coronavirus Task Force,’” Atlas notes, “but it was not in sync with President Trump. It was directed by Vice President Pence.” (Atlas, p. 306) Yet, whenever Atlas tried to raise questions about Birx’s policies, he was directed to speak with Pence, who then failed to ever address anything with Birx:

“Given that the VP was in charge of the Task Force, shouldn’t the bottom-line advice emanating from it comport with the policies of the administration? But he would never speak with Dr. Birx at all. In fact, (Marc) Short [Pence’s chief of staff], clearly representing the VP’s interests above all else, would do the opposite, telephoning others in the West Wing, imploring friends of mine to tell me to avoid alienating Dr. Birx.” (Atlas, p. 165-6)

Recall that Pence replaced Alex Azar as Task Force director on February 26, 2020 and Birx’s appointment as coordinator, at the instigation of Asst. National Security Advisor Matt Pottinger, came on February 27th. Subsequent to those two appointments, it was Birx who was effectively in charge of United States coronavirus policy.

What was driving that policy, once she took over? As Birx writes, it was the NSC (National Security Council) that appointed her, through Pottinger, and it was her job to “reinforce their warnings” – which, I continue to speculate, were related to the accidental release of an enhanced pandemic potential pathogen from a US-funded lab in Wuhan.

Trump was probably made aware of this, as evidenced not just by his repeated mentions, but by what Time Magazine called his uncharacteristic refusal to explain why he believed it. The magazine quotes Trump saying “I can’t tell you that,” when asked about his belief in the lab leak. And he repeats, “I’m not allowed to tell you that.”

Why in the world was the President of the United States not allowed to override AIDS researcher/diplomat Birx on lockdown policies nor explain to the public why he believed there was a lab leak?

The answer, I believe, is that Trump was uncharacteristically holding back because he was told (by Birx, Pottinger and the military/intelligence/biosecurity interests for whom they worked) that if he did not go along with their policies and proclamations, millions of Americans would die. Why? Because SARS-CoV-2 was not just another zoonotic virus. It was an engineered virus that needed to be contained at all costs.

As Dr. Atlas repeatedly notes with great dismay: “the Task Force doctors were fixated on a single-minded view that all cases of COVID must be stopped or millions of Americans would die.” (Atlas, p. 155-6) [BOLDFACE ADDED]

That was the key message, wielded with great force and success against Trump, his administration, the press, the states, and the public, to suppress any opposition to lockdown policies. Yet the message makes no sense if you believe SARS-CoV-2 is a virus that jumped from a bat to a person in a wet market, severely affecting mostly people who are old and debilitated. It only makes sense if you think, or know, that the virus was engineered to be especially contagious or deadly (even if its behavior in the population at any given moment might not justify that level of alarm).

But, again, before indulging in more speculation, let’s get back to Birx. Who else did she (and her hidden handlers) bulldoze?

She dictated policy to the entire Trump administration

In his book, Atlas observes with puzzlement and consternation that, although Pence was the nominal director of the Task Force, Deborah Birx was the person in charge: “Birx’s policies were enacted throughout the country, in almost every single state, for the entire pandemic—this cannot be denied; it cannot be deflected.” (Atlas, p. 222)

Atlas is “dumbstruck at the lack of leadership in the White House,” in which, “the president was saying one thing while the White House Task Force representative was saying something entirely different, indeed contradictory” and, as he notes, “no one ever set her [Birx] straight on her role.” (Atlas, p. 222-223)

Not only that, but no matter how much Trump, or anyone in the administration, disagreed with Birx, “the White House was held hostage to the anticipated reaction of Dr. Birx” and she “was not to be touched, period.” (Atlas, p. 223)

One explanation for her untouchableness, Atlas suggests, is that Birx and her policies became so popular with the press and public that the administration did not want to “rock the boat” by replacing her before the election. This explanation, however, as Atlas himself realizes, crumbles in the face of what we know about Trump and the media’s hostility towards him:

“They [Trump’s advisors] had convinced him to do exactly the opposite of what he would naturally do in any other circumstance—to disregard his own common sense and allow grossly incorrect policy advice to prevail. … This president, widely known for his signature ‘You’re fired!’ declaration, was misled by his closest political intimates. All for fear of what was inevitable anyway—skewering from an already hostile media.” (Atlas, p. 300-301)

I would suggest, again, the reason for the seemingly inexplicable lack of gumption on Trump’s part to get rid of Birx was not politics, but behind-the-scenes machinations of the (to coin a moniker) lab leak cabal.

Who else was part of this cabal with its hidden agendas and oversized policy influence? Our attention naturally turns to the other members of the Task Force who were presumably co-engineering lockdown policies with Birx. Surprising revelations emerge.

There was no troika. No Birx-Fauci lockdown plan. It was all Birx.

It is universally assumed, by both those in favor and those opposed to the Task Force’s policy prescriptions, that Drs. Deborah Birx, Tony Fauci (head of  NIAID at the time) and Bob Redfield (then director of the CDC) worked together to formulate those policies.

The stories told by Birx herself and Task Force infiltrator Scott Atlas suggest otherwise.

Like everyone else, at the onset of his book, Atlas asserts: “The architects of the American lockdown strategy were Dr. Anthony Fauci and Dr. Deborah Birx. With Dr. Robert Redfield… they were the most influential medical members of the White House Coronavirus Task Force.” (Atlas, p. 22)

But as Atlas’s story unfolds, he presents a more nuanced understanding of the power dynamics on the Task Force:

“Fauci’s role surprised me the most. Most of the country, indeed the entire world, assumed that Fauci occupied a directorial role in the Trump administration’s Task Force. I had also thought that from viewing the news,” Atlas admits. However, he continues, “The public presumption of Dr. Fauci’s leadership role on the Task Force itself…could not have been more incorrect. Fauci held massive sway with the public, but he was not in charge of anything specific on the Task Force. He served mainly as a channel for updates on the trials of vaccines and drugs.” (p. 98) [BOLDFACE ADDED]

By the end of the book, Atlas fully revises his initial assessment, strongly emphasizing that, in fact, it was primarily and predominantly Birx who designed and disseminated the lockdown policies:

“Dr. Fauci held court in the public eye on a daily basis, so frequently that many misconstrue his role as being in charge. However, it was really Dr. Birx who articulated Task Force policy. All the advice from the Task Force to the states came from Dr. Birx. All written recommendations about their on-the-ground policies were from Dr. Birx. Dr. Birx conducted almost all the visits to states on behalf of the Task Force.” (Atlas, p. 309-10) [BOLDFACE ADDED]

It may sound jarring and unlikely, given the public perception of Fauci, as Atlas notes. But in Birx’s book the same unexpected picture emerges.

Methinks the lady doth protest too much

As with her bizarrely self-contradictory statements about how she got hired, and her blatantly bogus scientific claims, Birx’s story about her mind-melded closeness with Fauci and Redfield falls apart upon closer examination.

In her book, Birx repeatedly claims she trusts Redfield and Fauci “implicitly to help shape America’s response to the novel coronavirus.” (Birx, p. 31) She says she has “every confidence, based on past performance, that whatever path the virus took, the United States and the CDC would be on top of the situation.” (Birx, p. 32)

Then, almost immediately, she undermines the credibility of those she supposedly trusts, quoting Matt Pottinger as saying she “‘should take over Azar, Fauci, and Redfield’s jobs, because you’re such a better leader than they are.’” (Birx, p. 38-9)

Perhaps she was just giving herself a little pat on the back, one might innocently suggest. But wait. There’s so much more.

Birx claims that in a meeting on January 31 “everything Drs. Fauci and Redfield said about their approach made sense based on the information available to me at that point,” even though “neither of them spoke” about the two issues she was most obsessed with: “asymptomatic silent spread [and] the role testing should play in the response.” (Birx, p. 39)

Then, although she says she “didn’t read too much into this omission,” (p. 39) just two weeks later, “as early as February 13” Birx again mentions “a lack of leadership and direction in the CDC and the White House Coronavirus Task Force.” (p. 54)

So does Debi trust Tony and Bob’s leadership or does she not? The only answer is more self-contradictory obfuscation.

Birx is horrified that nobody is taking the virus as seriously as they should: “then I saw Tony and Bob repeating that the risk to Americans was low,” she reports. “On February 8, Tony said that the chances of contracting the virus were ‘minuscule.’” And, “on February 29, he said, ‘Right now, at this moment, there is no need to change anything you’re doing on a day-to-day basis.’” (Birx, p. 57)

This does not seem like the kind of leader Birx can trust. She half-heartedly tries to excuse Redfield and Fauci, saying “I now believe that Bob and Tony’s words had spoken to the limited data they had access to from the CDC,” and then, in another whiplash moment, “maybe they had data in the United States that I did not.”

Did Tony and Bob provide less dire warnings because they had insufficient data or because they had more data than Birx did? She never clarifies, but regardless, she assures us that she “trusted them” and “felt reassured every day with them on the task force.” (Birx, p. 57)

If I was worried that the virus was not being taken seriously enough, Birx’s reports on Bob and Tony would not be very reassuring, to say the least.

Apparently, Birx herself felt that way too. “I was somewhat disappointed that Bob and Tony weren’t seeing the situation as I was,” she says, when they disagreed with her alarmist assessments of asymptomatic spread. But, she adds, “at least their number supported my belief that this new disease was far more asymptomatic than the flu. I wouldn’t have to push them as far as I needed to push the CDC.” (Birx, p. 78)

Is someone who disagrees with your assessment to the point that you need to push them in your direction also someone you “implicitly trust” to lead the US through the pandemic?

Apparently, not so much.

Although she supposedly trusts Redfield and sleeps well at night knowing he’s on the Task Force, Birx has nothing but disdain and criticism for the CDC – the organization Redfield leads.

“On aggressive testing I planned to have Tom Frieden [CDC director under Obama] help bring the CDC along,” she recounts. “Like me, the CDC wanted to do everything to stop the virus, but the agency needed to align with us on aggressive testing and silent spread.” (p. 122) Which makes one wonder: If she was so closely aligned with Redfield, the head of the CDC, why did Birx need to bring in a former director – in a direct challenge to the sitting one – to “bring the CDC along?” Who is “us” if not Birx, Fauci and Redfield?

Masks were another issue of apparent contention. Birx is frustrated because the CDC, led by her “we’ve-got-each-other’s-back” bestie, Bob Redfield (Birx, p. 31), will not issue strict enough masking guidelines. In fact, she repeatedly throws Bob’s organization under the bus, basically accusing them of causing American deaths: “For many weeks and months to come,” she writes, “I fretted over how many lives could have been saved if the CDC had trusted the public to understand that …masks would do no harm and could potentially do a great deal of good.” (Birx, p. 86)

Apparently, Fauci was not on board with the masking either, as Birx says that “getting the doctors, including Tom [Frieden] and Tony, to be in complete agreement with me about asymptomatic spread was slightly less of a priority. As with masks, I knew I could return to that issue as soon as I got their buy-in on our recommendations.” (Birx, p. 123)

Who is making “our recommendations” if not Birx, Fauci and Redfield?

The myth of the troika

Whether or not she trusted them (and it’s hard to believe, based on her own accounts, that she did), it was apparently very important to Birx that she, Fauci and Redfield appear as a single entity with no disagreements whatsoever.

When Scott Atlas, an outsider not privy to whatever power plays were happening on the Task Force, came in, his presence apparently rattled Birx (Atlas, p. 83-4), and for good reason. Atlas immediately noticed strange goings-on. In his book, he repeatedly uses words like “bizarre,” “odd” and “uncanny” to describe how Fauci, Redfield and Birx behaved. Most notably, they never ever questioned or disagreed with one another in Task Force meetings. Not ever.

“They shared thought processes and views to an uncanny level,” Atlas writes, then reiterates that “there was virtually no disagreement among them.” What he saw “was an amazing consistency, as though there were an agreed-upon complicity” (Atlas, pp. 99-100). They “virtually always agreed, literally never challenging one another.” (p. 101) [BOLDFACE ADDED]

An agreed-upon complicity? Uncanny agreement? Based on all of the disagreements reported by Birx and her repeated questioning and undermining of Bob and Tony’s authority, how can this be explained?

I would contend that in order to obscure the extent to which Birx alone was in charge of Task Force policy, the other doctors were compelled to present a facade of complete agreement. Otherwise, as with any opposition to, or even discussion of, potential harms of lockdown policies, “millions of Amercans would die.”

This assessment is strengthened by Atlas’s ongoing bafflement and distress at how the Task Force – and particularly the doctors/scientists who were presumably formulating policy based on data and research – functioned:

“I never saw them act like scientists, digging into the numbers to verify the very trends that formed the basis of their reactive policy pronouncements. They did not act like researchers, using critical thinking to dissect the published science or differentiate a correlation from a cause. They certainly did not show a physician’s clinical perspective. With their single-minded focus, they did not even act like public health experts.” (Atlas, p. 176)

Atlas was surprised, indeed stunned, that “No one on the Task Force presented any data” to justify lockdowns or to contradict the evidence on lockdown harms that Atlas presented. (Atlas, p. 206) More specifically, no data or research was ever presented (except by Atlas) to contradict or question anything Birx said. “Until I arrived,” Atlas observes, “no one had challenged anything she said during her six months as the Task Force Coordinator.” (Atlas, p. 234) [BOLDFACE ADDED]

Atlas cannot explain what he’s witnessing. “That was all part of the puzzle of the Task Force doctors,” he states. “There was a lack of scientific rigor in meetings I attended. I never saw them question the data. The striking uniformity of opinion by Birx, Redfield, Fauci, and (Brett) Giroir [former Admiral and Task Force “testing czar”] was not anything like what I had seen in my career in academic medicine.” (Atlas, p. 244)

How can we explain the puzzle of this uncanny apparent complicity by the Task Force troika?

Methinks the intelligence agent also doth protest too much

An interesting hint comes from the string of anecdotes comprising Matthew Lawrence’s New Yorker article “The Plague Year.” Lawrence writes that Matt Pottinger (the NSC liaison to Birx) tried to convince Task Force members that masking could stop the virus “‘dead in its tracks’” but his views “stirred up surprisingly rigid responses from the public-health contingent.” Lawrence continues to report that “In Pottinger’s opinion, when Redfield, Fauci, Birx, and (Stephen) Hahn spoke, it could sound like groupthink,” implying that those were the members of the “public-health contingent” who did not agree with Pottinger’s masking ideas.

But wait. We just noted Birx’s frustration, indeed deep regret, that the CDC led by Redfield, as well as Fauci (and even Frieden) did not agree with her ideas on asymptomatic spread and masking. So why does Pottinger imply that she and the “public-health contingent” of the Task Force were group-thinking this issue, against him?

I would suggest that the only way to make sense of these contradictions within Birx’s narrative and between her, Atlas and Pottinger’s stories, is if we understand “align with us” and “our recommendations” to refer not to the perceived Birx-Fauci-Redfield troika, but to the Birx-Pottinger-lab leak cabal that was actually running the show.

In fact, Birx and Pottinger put so much effort into insisting on the solidarity of the troika, even when it contradicts their own statements, that the question inevitably arises: what do they have to gain from it? The benefit of insisting that Birx was allied with Fauci, Redfield and the “public-health contingent” on the Task Force, I would argue, is that this deflects attention from the Birx-Pottinger-cabal non-public-health alliance.

Her authority and policies emanated from a hidden source

The explanation of Atlas’s perceived “puzzle of the Task Force doctors” that makes the most sense to me is that Deborah Birx, in contrast and often in opposition to the other doctors on the Task Force, represented the interests of what I’m calling the lab leak cabal: those not just in the US but in the international intelligence/biosecurity community who needed to cover up a potentially devastating lab leak and who wanted to impose draconian lockdown measures such as the world had never known.

Who exactly they were and why they needed lockdowns are subjects of ongoing investigations.

In the meantime, once we separate Birx from Trump, from the rest of the administration, and from the others on the Task Force, we can see clearly that her single-minded and scientifically nonsensical emphasis on silent spread and asymptomatic testing was geared toward a single goal: to scare everyone so much that lockdowns would appear to be a sensible policy. This is the same strategy that was, uncannily in my opinion, implemented almost to the letter in nearly every other country around the world. But that’s for the next article.

I’ll close this chapter of the Birx riddle wrapped in a mystery inside an enigma, with Scott Atlas’s report of his parting conversation with President Trump:

“‘You were right about everything, all along the way,’” Trump said to Atlas. “‘And you know what? You were also right about something else. Fauci wasn’t the biggest problem of all of them. It really wasn’t him. You were right about that.’ I found myself nodding as I held the phone in my hand,” Atlas says. “I knew exactly whom he was talking about.” (Atlas, p. 300)

And now, so do we.

Author

  • Debbie Lerman has a degree in English from Harvard. She is a retired science writer and a practicing artist in Philadelphia, PA.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Brownstone Institute

The WHO’s Proposed Pandemic Agreements Worsen Public Health

Published on

From the Brownstone Institute

BY David BellDAVID BELL

The WHO decided that the response for a Toronto aged care resident and a young mother in a Malawian village should be essentially the same – stop them from meeting family and working, then inject them with the same patented chemicals.

Much has been written on the current proposals putting the World Health Organization (WHO) front and center of future pandemic responses. With billions of dollars in careers, salaries, and research funding on the table, it is difficult for many to be objective. However, there are fundamentals here that everyone with public health training should agree upon. Most others, if they take time to consider, would also agree. Including, when divorced from party politicking and soundbites, most politicians.

So here, from an orthodox public health standpoint, are some problems with the proposals on pandemics to be voted on at the World Health Assembly at the end of this month.

Unfounded Messaging on Urgency

The Pandemic Agreement (treaty) and IHR amendments have been promoted based on claims of a rapidly increasing risk of pandemics. In fact, they pose an ‘existential threat’ (i.e. one that may end our existence) according to the G20’s High Level Independent Panel in 2022. However, the increase in reported natural outbreaks on which the WHO, the World Bank, G20, and others based these claims is shown to be unfounded in a recent analysis from the UK’s University of Leeds. The main database on which most outbreak analyses rely, the GIDEON database, shows a reduction in natural outbreaks and resultant mortality over the past 10 to 15 years, with the prior increase between 1960 and 2000 fully consistent with the development of the technologies necessary to detect and record such outbreaks; PCR, antigen and serology tests, and genetic sequencing.

The WHO does not refute this but simply ignores it. Nipah viruses, for example, only ‘emerged’ in the late 1990s when we found ways to actually detect them. Now we can readily distinguish new variants of coronavirus to promote uptake of pharmaceuticals. The risk does not change by detecting them; we just change the ability to notice them. We also have the ability to modify viruses to make them worse – this is a relatively new problem. But do we really want an organization influenced by China, with North Korea on its executive board (insert your favorite geopolitical rivals), to manage a future bioweapons emergency?

Irrespective of growing evidence that Covid-19 was not a natural phenomenon, modelling that the World Bank quotes as suggesting a 3x increase in outbreaks over the next decade actually predicts that a Covid-like event will recur less than once per century. Diseases that the WHO uses to suggest an increase in outbreaks over the past 20 years, including cholera, plague, yellow fever, and influenza variants were orders of magnitude worse in past centuries.

This all makes it doubly confusing that the WHO is breaking its own legal requirements in order to push through a vote without Member States having time to properly review implications of the proposals. The urgency must be for reasons other than public health need. Others can speculate why, but we are all human and all have egos to protect, even when preparing legally binding international agreements.

Low Relative Burden

The burden (e.g. death rate or life years lost) of acute outbreaks is a fraction of the overall disease burden, far lower than many endemic infectious diseases such as malaria, HIV, and tuberculosis, and a rising burden of non-communicable disease. Few natural outbreaks over the past 20 years have resulted in more than 1,000 deaths – or 8 hours of tuberculosis mortality. Higher-burden diseases should dominate public health priorities, however dull or unprofitable they may seem.

With the development of modern antibiotics, major outbreaks from the big scourges of the past like Plague and typhus ceased to occur. Though influenza is caused by a virus, most deaths are also due to secondary bacterial infections. Hence, we have not seen a repeat of the Spanish flu in over a century. We are better at healthcare than we used to be and have improved nutrition (generally) and sanitation. Widespread travel has eliminated the risks of large immunologically naive populations, making our species more immunologically resilient. Cancer and heart disease may be increasing, but infectious diseases overall are declining. So where should we focus?

Lack of Evidence Base

Investment in public health requires both evidence (or high likelihood) that the investment will improve outcomes and an absence of significant harm. The WHO has demonstrated neither with their proposed interventions. Neither has anyone else. The lockdown and mass vaccination strategy promoted for Covid-19 resulted in a disease that predominantly affects elderly sick people leading to 15 million excess deaths, even increasing mortality in young adults. In past acute respiratory outbreaks, things got better after one or perhaps two seasons, but with Covid-19 excess mortality persisted.

Within public health, this would normally mean we check whether the response caused the problem. Especially if it’s a new type of response, and if past understanding of disease management predicted that it would. This is more reliable than pretending that past knowledge did not exist. So again, the WHO (and other public-private partnerships) are not following orthodox public health, but something quite different.

Centralization for a Highly Heterogeneous Problem

Twenty-five years ago, before private investors became so interested in public health, it was accepted that decentralization was sensible. Providing local control to communities that could then prioritize and tailor health interventions themselves can provide better outcomes. Covid-19 underlined the importance of this, showing how uneven the impact of an outbreak is, determined by population age, density, health status, and many other factors. To paraphrase the WHO, ‘Most people are safe, even when some are not.’

However, for reasons that remain unclear to many, the WHO decided that the response for a Toronto aged care resident and a young mother in a Malawian village should be essentially the same – stop them from meeting family and working, then inject them with the same patented chemicals. The WHO’s private sponsors, and even the two largest donor countries with their strong pharmaceutical sectors, agreed with this approach. So too did the people paid to implement it. It was really only history, common sense, and public health ethics that stood in the way, and they proved much more malleable.

Absence of Prevention Strategies Through Host Resilience

The WHO IHR amendments and Pandemic Agreement are all about detection, lockdowns, and mass vaccination. This would be good if we had nothing else. Fortunately, we do. Sanitation, better nutrition, antibiotics, and better housing halted the great scourges of the past. An article in the journal Nature in 2023 suggested that just getting vitamin D at the right level may have cut Covid-19 mortality by a third. We already knew this and can speculate on why it became controversial. It’s really basic immunology.

Nonetheless, nowhere within the proposed US$30+ billion annual budget is any genuine community and individual resilience supported. Imagine putting a few billion more into nutrition and sanitation. Not only would you dramatically reduce mortality from occasional outbreaks, but more common infectious diseases, and metabolic diseases such as diabetes and obesity, would also go down. This would actually reduce the need for pharmaceuticals. Imagine a pharmaceutical company, or investor, promoting that. It would be great for public health, but a suicidal business approach.

Conflicts of Interest

All of which brings us, obviously, to conflicts of interest. The WHO, when formed, was essentially funded by countries through a core budget, to address high-burden diseases on country request. Now, with 80% of its use of funds specified directly by the funder, its approach is different. If that Malawian village could stump up tens of millions for a program, they would get what they ask for. But they don’t have that money; Western countries, Pharma, and software moguls do.

Most people on earth would grasp that concept far better than a public health workforce heavily incentivized to think otherwise. This is why the World Health Assembly exists and has the ability to steer the WHO in directions that don’t harm their populations. In its former incarnation, the WHO considered conflict of interest to be a bad thing. Now, it works with its private and corporate sponsors, within the limits set by its Member States, to mold the world to their liking.

The Question Before Member States

To summarize, while it’s sensible to prepare for outbreaks and pandemics, it’s even more sensible to improve health. This involves directing resources to where the problems are and using them in a way that does more good than harm. When people’s salaries and careers become dependent on changing reality, reality gets warped. The new pandemic proposals are very warped. They are a business strategy, not a public health strategy. It is the business of wealth concentration and colonialism – as old as humanity itself.

The only real question is whether the majority of the Member States of the World Health Assembly, in their voting later this month, wish to promote a lucrative but rather amoral business strategy, or the interests of their people.

Author

  • David Bell

    David Bell, Senior Scholar at Brownstone Institute, is a public health physician and biotech consultant in global health. He is a former medical officer and scientist at the World Health Organization (WHO), Programme Head for malaria and febrile diseases at the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, and Director of Global Health Technologies at Intellectual Ventures Global Good Fund in Bellevue, WA, USA.

Continue Reading

Brownstone Institute

Medical Elites’ Disgrace Over Ivermectin

Published on

From the Brownstone Institute

BY David GortlerDAVID GORTLER 

In the wake of the FDA settling a lawsuit brought against it for wantonly and aggressively smearing ivermectin, the agency has deleted its postings. That’s good, but we shouldn’t forget how egregiously it mischaracterized the drug, ignored copious evidence in its favor, and portrayed its proponents as dangerous crackpots.

About 30 months ago, America’s FDA was publishing articles with headlines like this: “Should I take ivermectin to treat COVID?” Answer: No. The agency also told Americans not to use ivermectin to prevent Covid. Then, in what became known as its infamous “horse tweet,” the FDA even patronizingly told Americans: “Seriously, y’all. stop it.

Prescribers who advocated for alternate treatments like ivermectin or hydroxychloroquine were mocked online by America’s “trusted journalists” as being part of a “right-wing conspiracy” and labeled “hucksters.” Those who didn’t demure to the Covid mRNA or other Big Pharma treatment narratives were banned, fired, and spoken harshly about around the world and into the reaches of the stratosphere in what seemed like coordinated messaging.

Many clinicians lost their jobs – at best. At worst, their reputations, practices, finances, and careers were shattered. If that was not bad enough, after losing their jobs, state medical and pharmacy boards initiated legal proceedings against their licensure, singling out their “off-label” Covid treatments, despite other off-label treatments being a near-ubiquitous component of pharmacy and medical practice.

A screenshot of a social media post Description automatically generated

Within days of FDA’s initial postings above, the American Pharmacist’s Association (APhA) the American Society of Health System Pharmacists (ASHP), and the American Medical Association (AMA) all collaborated to release a joint press release condemning doctors who prescribed ivermectin to treat Covid, but it appears that these organizations, instead of actually performing independent analysis of primary literature data, blindly regurgitated FDA, CDC, and NIH plus other government and Big Pharma talking points “strongly opposing” ivermectin use.

For generations and especially during the Covid pandemic, professionals depended on these “elite” medical groups. Some of them have existed for around 170 years and have around $150 million to $1.2 billion in assets, so they clearly had the history, personnel, and wherewithal to objectively examine published data. Even beyond that, the AMA has several floors in a skyscraper in Chicago and the APhA’s Constitution Avenue’s “landmark headquarters” is so luxuriant that it is advertised and utilized as a wedding venue.

Of course, that extravagance was paid for by millions of pharmacists, physicians, and benefactors who expected these organizations to act as a checksum and ensure excellent clinical practice standards. These medical organizations have a duty to honor their histories, responsibilities, and ethical duties to better the human condition through verified scientific evidence. Instead, they appeared to outrageously abandon their obligations from their lofty positions of respect, comfort, money, and power.

APhA, ASHP, and AMA Clinical Declarations Now Indefensible:

On March 22, the FDA rightly acquiesced and agreed to remove their anti-ivermectin postings due to 1) a lawsuit filed against them and 2) the impossible task of having to defend themselves with an overwhelming amount of data disagreeing with not only dispensing medical recommendations, but the published data backing their Covid-19 use (e.g., see below).

With that gone, the APhA, ASHP, and AMA assertions suddenly have no leg upon which to stand.

Several non-FDA links within their press releases have (unsurprisingly) also quietly vanished with no explanation. NIH references are slated to be shut down, on top of multiple FDA and CDC links already no longer working.

Ivermectin Mechanism of Action, History and Evidence:

The broad antiviral mechanism of action of ivermectin is complicated and may partially involve blocking the uptake of viral proteins, but the bottom line is that it has been shown to yield positive results in a variety of published results for Covid-19. Had APhA, ASHP, and AMA pharmacists and physicians independently examined the data, (as I, just one drug-safety analyst without fancy headquarters, have done) rather than simply parroting now-deleted narratives of others, they would have learned that ivermectin works as an antiviral.

It has an extensively proven track record of being not just safe – but astonishingly safe for a variety of viral diseases. This is not breaking or fringe science; it has been known for years. Ivermectin is such a safe and effective drug that back in 2015 it was the first drug for infectious disease associated with a Nobel Prize in 60 years.

While I have stacks of electronic files and printed materials, dog-eared and food/drink-stained, there is a most elegantly presented meta-analysis website designed by some brainy and web-savvy scientists detailing over 100 studies from over 1,000 different scientists, involving over 140,000 patients in 29 countries describing the benefit and safety of ivermectin for Covid-19 treatment. It actually appears to be more extensive than Cochrane’s outdated review of ivermectin which only examined 14 trials – and excluded seven of them from consideration.

A close-up of a blue sign Description automatically generated

According to these data, consisting of smaller international publications that include real-world findings and small observational studies, ivermectin shows a statistically significant lower Covid-19 risk as detailed in the image above.

The less-positive findings associated with late treatment/viral clearance/hospitalization data cohort were associated with delayed administration. That is because any late-state use of antiviral pharmacology tends to be ineffective after hundreds of millions of viral replications have taken place – whether it’s cold sores, influenza, AIDS, or Covid-19.

ASHP, APhA, and AMA Press Releases Contradict Available Data and Clinical Practice Standards:

When the FDA scolded Americans not to use ivermectin for Covid-19, on April 25, 2021, there were 43 different published manuscripts showing its potential benefit. Around three months later, on August 21, the FDA released its infamous horse/cow tweet which implied that ivermectin was only for animals, not humans. This “doubling down” occurred as an additional 20 studies had subsequently been written detailing additional benefits for Covid-19. See the timeline below:

In the picture shown above, the BLUE circles shown are studies which detail positive ivermectin study findings and the RED circles are negative. Negative data exists, but the positive ivermectin findings outnumber them both in study quantity and study size (illustrated by the circle sizes), according to meta analysis data published at: c19ivm.org

Multiple APhA/ASHP/AMA statements ignored published scientific and clinical evidence. Specifically, statements declaring the: “Use of ivermectin for the prevention and treatment of COVID-19 has been demonstrated to be harmful to patients” (bold emphasis theirs) are objectively inaccurate. I do not know on what basis those statements were made. The recommendation to healthcare professionals to …counsel patients against use of ivermectin as a treatment for COVID-19, including emphasizing the potentially toxic effects of this drug” represents a departure from pharmacist and physician practice standards.

The absurdity of the latter statement is quite outrageous. Pharmacists and physicians know that all drugs have “…potentially toxic effects” so if they applied the standard of “emphasizing potentially toxic effects” while discussing every prescribed medication, few if any patients would ever take any of their medications. The APhA/ASHP/AMA discriminatory hostility towards ivermectin was not only clinically unjustified and irresponsible; it was – as far as I know – without precedent.

These anti-ivermectin talking points also benefited new Big Pharma product advancement including the rebounding, overpriced taxpayer-funded boondoggle of Paxlovid and Remdesivir, such a “safe and effective” drug that hospitals had to be heavily incentivized (i.e., bribed) to entice nurses, physicians, and hospital administrators to promote its use with a staggering 20% “bonus” on the entire hospital bill paid by our federal government. Remdesivir quickly earned the sardonic nickname of “run-death-is-near” by American Frontline Nurses and others, due to serious questions about its clinical benefit.

Why were federal agencies’ and professional organizations’ talking points against ivermectin not backed by independent, original APhA/ASHP/AMA data examinations? That question needs to be thoroughly probed with regard to potential regulatory capture within these groups.

Both then and now, those FDA webpages, postings, and tweets were not just biased. They were irresponsible in their denigrating ivermectin as an off-label treatment, which is why they are now gone.

The question is, who was worse? The FDA for overstepping its congressional authority in not just making medical recommendations, but making recommendations ignoring data, or the servile “independent” elite professional organizations exuberantly echoing a narrative?

Prescient or not, here is an excerpt of the expert panel congressional testimony to the Covid Select House Oversight Committee, explaining the FDA’s disparaging ivermectin versus promoting mRNA injections using an automobile analogy, delivered just one day prior to the FDA’s yielding to physicians’ lawsuit to remove its postings denigrating ivermectin:

Heritage Foundation on X: ““To the countries, physicians, & pharmacists who prescribed ivermectin or hydroxychloroquine, I would like to tell you right now, you were right.” Dr. Gortler obliterated the “science” Americans were expected to believe about COVID treatments and the COVID vaccine in Congress… https://t.co/UJInVqdSdb” / X (twitter.com)

Despite FDA Settlement and Data Abundance, the Press is Still Anti-Ivermectin

Even after the FDA’s about-face, on March 26, 2024, a Los Angeles Times journalist published a column calling the removal of FDA tweets “groundless” unilaterally declaring ivermectin is still “conclusively shown to be useless against COVID-19,” comparing ivermectin to “snake oil,” and describing those who advocate for it as “purveyors of useless but lucrative nostrums” …whatever that means. (Regarding the ‘lucrative’ claim, it is worth noting that since ivermectin is generic and inexpensively available, it is not ‘lucrative’ to anyone.) It also referenced ivermectin lacking “scientific validation,” even though the above-cited data abundantly indicates otherwise.

Regarding the FDA’s choice to settle its lawsuit disparaging ivermectin, the FDA’s Center for Drug Evaluation and Research leadership isn’t “shooting itself in the foot” as the Times says. It seems that the FDA is indirectly attempting to prevent further embarrassment likely because it now realizes that its ivermectin assertions were wrong and outdated with every passing day. But where does that leave the APhA, ASHP, or AMA who heavily relied on these now deleted FDA links in their press releases?

The APhA, ASHP, AMA Response to the FDA’s Removal of Postings Used in Press Releases? An Embarrassing Silence:

Over a month later, and as of this publication date, none of these organizations have a single thing to say about their previous press releases quoting the now-removed FDA articles and tweets. In fact, here is an indication of their concerns: one week after the FDA acquiesced to remove its postings in ivermectin, APhA’s newly elected speaker chair and pharmacist Mary Klein is “happy danc[ing]” and giving her official acceptance speech wearing Mickey Mouse ears. ASHP’s (A/K/A “#MedicationExperts”) still shows its official page with clinicians wearing ineffective, unnecessary surgical masks despite the pandemic having ended well over a year ago and Cochrane reviews indicating that this sort of masking is almost certainly ineffective. AMA officials are making multiple posts on transgender issues and declaring climate change a public health crisis, – all while fully ignoring its impactful, incorrect, inappropriate statements on ivermectin.

Take a look:

The APhA, ASHP, and AMA have remained conspicuously silent on this topic while focusing their newsfeeds on everything but. To this day, their press releases remain online, with multiple dead links to government agencies. In blindly backing incorrect narratives pointing to removed web pages, they are now all alone in their ivermectin declarations.

Bottom line: ivermectin was and is safe, and more than likely effective for Covid when timed and dosed correctly, and under medical supervision, despite what was declared by organizations and federal officials. In fact, ivermectin’s general antiviral activity might even be helpful for bird flu (avian influenza) in animals and humans, in lieu of another novel adverse-event-ridden “warp speed” mRNA “vaccine” with an endless boondoggle of boosters.

The past and current record on ivermectin needs to be set straight. We know there is an important (but untransparent) list of who is responsible for misrepresenting published data, but will anyone be held accountable?

DISCLAIMER:  Do NOT discontinue or initiate taking ANY drug without first discussing it with a pharmacist or physician you know and trust. 

Author

  • David Gortler

    Dr. David Gortler, a 2023 Brownstone Fellow, is a pharmacologist, pharmacist, research scientist and a former member of the FDA Senior Executive Leadership Team who served as senior advisor to the FDA Commissioner on matters of: FDA regulatory affairs, drug safety and FDA science policy. He is a former Yale University and Georgetown University didactic professor of pharmacology and biotechnology, with over a decade of academic pedagogy and bench research, as part of his nearly two decades of experience in drug development. He also serves as a scholar at the Ethics and Public Policy Center

Continue Reading

Trending

X